Octavius Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.09 Cr
as on 16-11-2024
- Revenue -1.64%
(FY 2023)
- Profit -13.80%
(FY 2023)
- Ebitda -11.72%
(FY 2023)
- Net Worth 13.28%
(FY 2023)
- Total Assets 4.10%
(FY 2023)
About Octavius Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.09 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kirtan Deepakkumar, Jyotiben Padia, Nirali Padia, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231GJ2004PTC044024
- Company No.
044024
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Apr 2004
- Date of AGM
31 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Octavius Pharma Private Limited offer?
Octavius Pharma Private Limited offers a wide range of products and services, including Pharmaceutical Capsules, Softgel Capsules, Hair Growth Medicine, Hair Growth Capsules, Pain Killers, Pain Relief Cream, Herbal Capsules, Curcumin Piperine Capsule, Herbal Cough Syrup, Ayurvedic Cough Syrup.
Who are the key members and board of directors at Octavius Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirali Padia  | Director | 21-Aug-2018 | Current |
| Jyotiben Padia | Director | 23-Apr-2004 | Current |
| Kirtan Deepakkumar | Director | 23-Apr-2004 | Current |
| Deepakkumar Padia | Director | 23-Apr-2004 | Current |
Financial Performance of Octavius Pharma.
Octavius Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.64% decrease. The company also saw a substantial fall in profitability, with a 13.8% decrease in profit. The company's net worth Soared by an impressive increase of 13.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Octavius Pharma?
In 2023, Octavius Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Octavius Lifesciences Private LimitedActive 1 year 6 monthsKirtan Deepakkumar and Nirali Padia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Apr 2013 | ₹9.90 M | Satisfied |
Bank Of Baroda Creation Date: 08 Dec 2009 | ₹1.00 M | Satisfied |
How Many Employees Work at Octavius Pharma?
Unlock and access historical data on people associated with Octavius Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Octavius Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Octavius Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
